• Assesses psychosocial functioning in Type 2 diabetes across three domains: Psychological Distress (7 items); Barriers to Activity (6 items); Disinhibited Eating (5 items).
• A large sample of Type 1 and Type 2 people with diabetes (n=1,802) collected in one United Kingdom health authority area was used (Table 1 ).
• Data was collected longitudinally at two time points (baseline and one year follow up).
• Subsamples of the data were used for each regression model based on the numbers of respondents reporting clinical concerns across the timepoints used.
• The relationship between the DHP-18 and a number of variables, including diabetes specific
• Descriptive analysis of those reporting clinical concerns, and change in presence of absence of clinical concerns over time, was carried out.
• Ordinary least squares regression was used to assess the relationship between DHP dimension scores (dependent variables) and clinical indicators (independent variables).
• Logit regression was used to assess the relationship between change in clinical condition (independent variables) and DHP dimension scores and demographics (independent variables).
• Psychological distress scores are significantly associated with eye and foot related complications and co-morbid conditions including depression.
• Barriers to activity scores are significantly associated with duration of diabetes, eye and foot related complications and a range of co-morbid conditions including depression and lung disease.
• This study had demonstrated that higher scores (increasing dysfunctioning) on the psychological distress, perceived barriers to activity and disinhibited eating domains of the Diabetes Health Profile (DHP-18) are statistically associated with a range of variables, including diabetes-related complications, comorbidity and duration of diabetes. There was also initial evidence of an association between change in DHP-18 domain scores and change in severity of some clinical conditions.
• These findings indicate that the DHP-18 might be an appropriate diabetes specific patient reported outcome measure for predicting therapeutic response and clinical success in some health areas. • Disinhibited eating scores are significantly associated with duration of diabetes, the number of associated problems and co morbid conditions such as bone and lung disease. Relationship between change in DHP score and change in presence of clinical conditions (Table 3) • The DHP dimension scores are significantly associated with change in levels of anxiety and depression, but evidence is more mixed across the other clinical indicators.
• TABLE 3 and co-morbid health complications and length of time diagnosed were assessed. This was done cross-sectionally and longitudinally.
